CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Posts Q3 2019 Financial Results, Operations Update

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Thursday announced its financial and operating results for the three and nine months ended September 30, 2019. Among other highlights, the company reported that it ended the quarter with around $23.2 million of working capital and $24 million of cash on hand. Willow’s unaudited condensed consolidated interim financial statements and related management’s discussion and analysis are available at www.SEDAR.com or on the company’s website. “Over the past few months, Willow has continued to advance its business strategy and achieved several important milestones,” Willow Biosciences president and chief executive officer Trevor Peters stated in the news release. “We have made meaningful progress on advancing our yeast strain performance and fully expect to meet our projected timing of scale-up development in the first half of 2020. In addition, we have completed the commissioning of our three labs and expanded our team of highly skilled scientists, preparing us for future development. As the market for CBD and other cannabinoids continues to develop, Willow is positioned as a leader in delivering ultra-pure, pharmaceutical grade cannabinoids, at a highly competitive cost for the consumer packaged goods and pharmaceutical industries.”

To view the full press release, visit http://cnw.fm/2PpHt

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Dream Job? Earn 36k a Year to Smoke Marijuana Daily

A cannabis company has a job offer for potheads, cannabis products reviewer. The lucky person will be testing a wide range of marijuana products daily from the comfort of his/ her house. This lucky individual will then be paid $36,000 per year, which equates to $3,000 each month.

American Marijuana is among the most trusted online resource for medical marijuana, and the company is looking for a person who can give unbiased reviews and honest opinions about their wide range of products. The job is significant, and 100% legit.

However, American Marijuana is not employing someone just because they love smoking weed. According to their website, they put a disclaimer to indicate that people should not expect to be hired just because they can use pot. They further said that they are also looking to see if the individual has in-depth knowledge of cannabis, which can be applied to educate their readers. The chosen individual has to be residing in the United States or Canada where marijuana is legal. The candidate has to be fit, healthy, 18 years and above, and be comfortable in front of a camera.

Maybe having a degree in marijuana will be an added advantage.

The nitty-gritty of the job description is that they are looking for a person who can write reviews on a variety of marijuana products, which includes vapes, cannabis strains, edibles, and CBD oils. The person will also provide readers with candid and reliable information on the products.

At the beginning of every month, a box packaged with different brands and strains of marijuana will be shipped to the hired individual. The products include vapes, edibles, and CBD oils.

The lucky applicant is expected to record the unboxing and their experience on film. They are also required to test the products and write in a blog about their experience as well as everything else they will be doing with the products.

They are expected to give detailed write-ups of their experience during and after use. This is to educate readers and video viewers on the impact of the products.

According to the terms and conditions of the job advert, the $3,000 salary is dependent on the experience and capability of the applicant.

Marijuana is becoming more mainstream with each passing year, so it isn’t surprising that such job offers are beginning to popup. Cannabis industry analysts expect sector players like Willow Biosciences Corp. (CSE: WLLW) and Neutra Corp. (OTC: NTRR) to come up with novel jobs that pay handsomely.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Study Finds That Marijuana Use Disorder is Declining

According to a new study, the number of people diagnosed with cannabis use disorder (CUD) is not increasing. The results contradict the expectation of public health experts who thought that due to the legalization of marijuana, more people would consume more and more weed. The incidence of CUD is decreasing, and this could be attributed to the growing number of states that have made marijuana legal.

According to the report, between the years 2002 and 2016, the frequency of CUD decreased significantly across people of all ages. The decrease in cannabis dependence was noticed in adolescents, and young adults and stability in the use of marijuana were noted amongst adults aged 26 years and above who reported daily or almost daily consumption.

Recent studies on the use and misuse of marijuana had mixed results on the frequency of CUD in the last 20 years. This is because people who tend to use marijuana daily or almost daily are at the most risk for CUD. The researchers at Columbia University’s Mailman School of Public Health decided to study this group of consumers to get a better understanding of their general health.

Last month, the journal on Drug and Alcohol Dependence published the study findings.

The researchers used data from the National Surveys on Drug Use and Health for the years 2002 to 2016. This included 22,651 participants aged 12 years and above who reported having used weed at least 300 days within the past year.

The study authors used the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, to measure problematic marijuana use for marijuana dependence and marijuana abuse. These include:

The time spent in a month procuring, consuming, and getting over the effects of weed.
Inability to stick to the set consumption limits
Failure to reduce the amount and the number of times of cannabis consumption.
The failure to fulfill significant responsibilities due to the frequent use of weed. And,
The continued use of cannabis even though you are faced with persistent, or interpersonal problems.

The study authors considered other factors such as the perceived need for mental health treatment among the participants, and whether the health provider indicated other health issues. They were also asked if they have participated in impaired driving from illicit drugs with or without alcohol.

During the study, the authors found that the rate of CUD decreased across all age groups. For those between the age of 12 to 17 years the reduction was26.8%; 18 to 25 years by 29.7%, and adults older than 26 years by 37.5%.

The study also noted that there was a reduction in the frequency of DSM-IV weed abuse across all age groups; adolescents, young adults, and adults for those with past-year daily/almost daily marijuana consumption. They also noted a decrease in the frequency of DSM-IV marijuana dependence in adolescents and young adults.

The researchers attribute the decrease in CUD prevalence to the increased legalization of marijuana, whereby 33 states have legalized medical marijuana, and ten states have legalized recreational marijuana, said one of the study authors, Silvia Martins, in a statement. Legalization has contributed to the reduction of marijuana stigma and the perception of problems associated with the consumption of cannabis. It has also improved the changes in social attitudes since consumers no longer quarrel with relatives and friends about marijuana usage.

Industry watchers are of the view that the findings of this study vindicate the cannabis industry, including companies like Willow Biosciences Inc. (CSE: WLLW) and Sugarmade Inc. (OTCQB: SGMD) that would never participate in an industry that wilfully gets people hooked on a substance.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) today announced its plans to participate in the Cowen 2nd Annual Boston Cannabis Conference, a carefully curated event to represent leading-edge companies across a wide array of products, brands, technologies, services and health care providers in the emerging cannabis industry. According to the update, the event is scheduled to be held at the InterContinental Boston on November 12-13, 2019. Willow Vice President, Commercial Operations Dr. Chris Savile will be speaking on a Biosynthesis panel on November 13 at 8:50 AM ET. In addition Dr. Savile and Willow CFO Travis Doupe will be available for meetings throughout the conference, which can be arranged through Cowen’s one-on-one meeting system.

To view the full press release, visit http://cnw.fm/xU0hP

About Willow Biosciences Inc.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Congressional Committee Votes to Repeal Law Denying Students Aid Due to Drug Convictions

On Thursday, a Congressional committee approved legislation repealing the federal law that punishes college students who are ex-convicts of marijuana charges by denying or stripping them of their financial aid. The rule was enacted in 1998, by the Higher Education Act Aid Elimination Penalty. It has denied thousands of students’ access to means of paying tuition because of minor marijuana offenses.

Marijuana critics said that denying students access to financial aid is a counterproductive way of responding to drug use and misuse. According to the executive director of Students for Sensible Drug Policy, Betty Aldworth, the best intervention amongst the youth is providing them with quality education. She further noted that denying them access to means of furthering their education harms the students and the communities.

Apart from removing the penalty, the drug conviction question on the Free Application for Federal Student Aid (FAFSA) is also to be removed by the House Education and Labor Committee.

In 2006, the rule was amended from all past offenses to those convicted while on financial aid programs. Marijuana advocates said that the FAFSA question is unclear, and this has caused many eligible students not to apply.

The deputy director of national affairs for the Drug Policy Alliance, Grant Smith, said that they are aware that the question confuses students whereby those who have had an interaction with the police may not complete the FAFSA application process after deeming themselves unqualified.

The HEA legislation reform is to be eventually voted upon by the Senate, and it is uncertain if the Republican-controlled chamber will approve the drug penalty repeal.

Several advocacy groups are working to delete the drug conviction penalty and reinstate the financial aid accessibility to incarcerated college students. These include the SSDP, DPA and other stakeholders associated with Unlock Higher Ed Coalition.

According to Aldworth, young people’s opinions are crucial for the success of movements geared towards social change because they are the ones who are directly affected by injustice. He went ahead and said that SSDP has been working for the last 20 years to make education accessible to all Americans, particularly those who are caught using drugs.

The coalition brought those affected by the federal law to Capitol Hill to meet with the legislators and staffers to show how the rule affects criminally convicted students, and to show that only those who need the financial aid are affected, said Smith.

The advocates also noted that people from families that are financially stable do not have to worry about losing their financial aid over marijuana or any other drug conviction. They further argued that the law to be repealed is discriminatory because it is enforced more strictly on people of color, even though almost all people, irrespective of color, use drugs.

According to Aldworth, black youths are affected by the federal rules just as the black people are the main targets of war against drugs.

Earlier this year, Senator Cory Booker filed a legislation calling for the removal of drug conviction question from the FAFSA. Analysts are uncertain as to what marijuana companies like Willow Biosciences Inc. (CSE: WLLW) and Hemptown USA think about the chances of this proposed law reaching the desk of the President for enactment.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Begin Trading on the OTCQB® Venture Market

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced that it has been approved to commence trading on the OTCQB® Venture Market (the “OTCQB”), under the symbol “CANSF,” beginning today, November 5, 2019. The listing will enable Willow Biosciences access to a broader base of U.S. and international retail and institutional investors, ultimately providing increased data access, transparency and liquidity to investors. “Listing on the OTCQB will allow for greater engagement with our U.S. investor base,” Willow CEO Trevor Peters said in the news release. “As we move towards scale up of ultra-pure, pharmaceutical grade cannabidiol (“CBD”) with our partner Noramco, Inc., we are happy to provide U.S. investors with an easier platform to invest in our company.”

To view the full press release, visit http://cnw.fm/gQU9a

About Willow Biosciences Inc.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CBDWire

CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CBDW? Ask our Editor

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Bernie Sanders Releases His Proposal for Legalizing Marijuana at 4:20

On Thursday, Senator Bernie Sanders released his proposal for legalizing marijuana at 4.20 pm EST. Among weed users 4.20 is referred to as weed or marijuana day.

Senator Sanders is a Democratic presidential candidate, and he proposes to legalize marijuana through executive action within 100 days. His proposal also addresses the potential problems of marijuana and criticizes the method some states have used to legalize the drug. His plan also limits the size and scope of the cannabis industry by implementing procedures that ensure that marijuana legalization offers benefit to the people of color.

He says his first move will be to give a direct order of marijuana declassification as a controlled substance to the Attorney General. Declassification of marijuana is the process of removing it from the list of controlled substances and legalizing it at the federal level.

Senator Sanders’ intention is to push Congress to legalize marijuana permanently at the federal level after which the states would be permitted to legalize cannabis within their states.

Marijuana remains illegal federally despite being legalized in Washington DC and 11 other states.

The federal law has imposed several barriers on state-legal marijuana businesses and among these barriers is that the businesses operate on a cash-only basis since banks would be breaking federal law if they conducted business with marijuana businesses. Furthermore, the inability of marijuana businesses to file several deductions causes their income tax to increase to 90 percent-plus. The classification of marijuana as a controlled substance is also a reason why the restrictions are there. However, compared to other drugs, federal punishment for marijuana is lenient.

His administration plans on rallying the state and federal authorities to decriminalize past marijuana convictions. He also plans on setting up an independent clemency board responsible for granting early release to those who are federally convicted, as noted in his criminal justice reforms.

In his proposal, he promises to create a $20 billion grant program from marijuana tax revenue for black entrepreneurs who have challenges accessing capital for their businesses and an additional $10 billion grant program for companies in disadvantaged areas owned or controlled by people who have been arrested for marijuana crimes.

He also promises a $10 billion grant program for former marijuana convicts to start growing marijuana in their rural or urban farms and a development fund of $10 billion for the communities most affected by the War on Drugs.

Sanders also plans on sensitizing marijuana businesses to transition into non-profits, to ban products and labels meant to attract the young generation as well as ban other companies producing products that cause cancer such as tobacco companies.

Except for Joe Biden, all other Democrats are in support of marijuana legalization. A recent survey by Gallup showed that 66 percent of Americans are in favor of legalization, and this includes 76 percent of Democrats and 51 percent Republicans.

Many are eager to hear what marijuana companies like Willow Biosciences Inc. (CSE: WLLW) and LiveWire Ergogenics Inc. (OTC: LVVV) have to say about these proposals and their practicability.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Ruling Party in Scotland Supports Decriminalizing Drugs

On Sunday, Scottish National Party delegates, in a unanimous vote, approved a resolution calling for the decriminalization of drug possession and consumption.

The lawmakers representing the Scottish National Party, which is the third-largest party in the UK Parliament, in a conference in Aberdeen, argued that the parliament should remove criminal charges from drug offenses, and addiction should be addressed as a public health problem so as to control the overdose crisis in Scotland.

The resolution is an amendment to the 1971 Misuse of Drugs Act which states that we are in the 21^st century and the current law is not apt; therefore, a provision should be added that permits removal of criminal penalties for possession and consumption of controlled medicine such as marijuana so that physicians can use it as treatment for those who need it.

The SNP Members of Parliament introduced the measure. These include Tommy Sheppard, Ronnie Cowan, and Alison Thewliss.

According to Sheppard, instead of the Scotland law enforcement agencies focusing on the organized criminals at the top, their primary focus is on the weak and vulnerable.

If the UK government does not pursue the proposed reform, then it should give the power to Scotland because they will take the necessary steps to approve the motion, added Sheppard.

Many people who have experienced trauma most often self-medicate, which eventually leads to addiction, notes Cowan.

Cowan said that decriminalization places drugs in a health area such as dispensary, thus demystifying the medicine. He further added that drug laws are all about one’s mindset, and once the drug is decriminalized, the mindset changes, and this allows you as a physician to treat people as human beings, and as a result, the recovery process is started.

Conferences held in the past by the Scottish National Party had seen the approval of proposed drug reforms, such as establishing safe consumption sites that would help people transition into treatment, thus, preventing overdoses, Common Space Reports. The UK Parliament has resisted such harm reduction policies, and this has frustrated reform advocates.

A Royal Commission whose work is to review the country’s drug laws if voted by the majority will be launched, announced the Labour Party last month.

Thewliss said that the UK government’s attitude toward Scotland’s drug emergency is inexcusable. He added that while the Tories at Westminster take no action, hundreds of people are dying on the street while the public is at risk of improper disposal of needles and increased transmission of blood-borne diseases.

Mhairi Hunter, the Glasgow Councillor, while at the conference, said that challenging the stigma around addiction is the same as challenging the laws criminalizing addiction.

In the U.S, lawmakers are still focused on reforming marijuana laws. According to a survey released earlier this month, about 55% of Americans support decriminalization of marijuana possession and consumption. In the course of their presidential campaign, candidate Pete Buttigieg and Tulsi Gabbard voiced their support for the policy.

Analysts think marijuana companies like Willow Biosciences Inc. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI) would want the Scottish view to be adopted in more jurisdictions, especially by the U.S. federal government.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Five Benefits of Marijuana to Seniors

Our bodies demand more care as we age. By the year 2030, one estimate suggests that the number of seniors with some ailment will be double the current number. This equates to 15 million senior citizens. The forecast prompted the search of ways in which cannabis can help improve the lives of the elderly.

The good thing is that cannabis is still considered as a newcomer in the medical field, so it has a lot of untapped potential. It is not a wonder to see more research on the effects of marijuana and its impact on the elderly in the future. Discussed below are five ways marijuana benefits seniors.

Marijuana Improves Quality of Life

Most of our body organs begin to fail as we get older, which is the most significant source of pain and discomfort in seniors. More so, the probability of the elderly experiencing inflammation, high blood pressure, mental and bone issues is very high. Studies show that the best way of getting relief from these ailments is by using marijuana.

Safety

America is facing a severe crisis of Opioid-related deaths; therefore, the U.S should come up with a plan of regulating medical marijuana to patients as this will diminish use of opioid drugs. Contrary to the famous belief that opioids affect the younger generation, a survey carried out in 2018 shows that more than 2.8 million seniors abused prescription drugs. Seniors consuming opioids have high chances of falling; thus, ending up in nursing homes. The risks can be reduced by giving them an appropriate dosage of cannabis instead of letting them rely on opioids.

Fosters a Sense of Community

Seniors are prone to loneliness which is the primary cause of depression, diseases, and sometimes death. Marijuana consumption enhances the mind, and this could help the seniors by improving their creativity and social skills. It also enables them to go into relaxation mode.

It is Natural

Marijuana medicines are made from the natural components of marijuana, such as CBD. CBD helps treat patients gently and carefully. The marijuana plant has multiple uses and can be consumed through several methods such as baking cookies, applying oils on the body, vaping, or smoking. It helps in managing a wide range of diseases and managing symptoms of conditions such as epilepsy and autism.

Does not Cause a High

Being a little high is not bad for the mind; however, it is not a must for the seniors to get high to get relief. Experts have come up with medical marijuana rich in the nonpsychoactive compound of marijuana known as Cannabidiol (CBD). CBD does not give the high effect of weed, so seniors can benefit from marijuana without being high.

Experts believe that it such huge benefits to this important demographic that urge marijuana industry players like Willow Biosciences Inc. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI) to keep searching for better ways to formulate products for different segments of the population.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen’s Park Ballroom.

To view the full press release, visit http://cnw.fm/LS4j3

About Willow Biosciences Inc.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com